Malignant effusions and immunogenic tumour-derived exosomes

This publication has 27 references indexed in Scilit:

• In vitro induction of tumor-specific human lymphocyte antigen class I–restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen–pulsed autologous dendritic cells from patients with advanced ovarian cancer
  American Journal of Obstetrics and Gynecology, 2000
• Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization
  The Journal of Experimental Medicine, 1999
• Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
  The Lancet, 1999
• Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes
  Nature Medicine, 1998
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
  Nature Medicine, 1998
• Purification of Heat Shock Protein–Peptide Complexes for Use in Vaccination against Cancers and Intracellular Pathogens
  Methods, 1997
• B lymphocytes secrete antigen-presenting vesicles.
  The Journal of Experimental Medicine, 1996
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
  Nature Medicine, 1996
• Intraperitoneal Adoptive Immunotherapy of Ovarian Carcinoma with Tumor-Infiltrating Lymphocytes and Low-Dose Recombinant Interleukin-2
  Journal of Immunotherapy, 1994
• Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
  The Journal of Experimental Medicine, 1983